• OGÊÓѶ¹ÙÍøÊµÑéСÊó

    Éñ¾­ÍËÐÐÐÔ¼²²¡Ä£ÐÍ

    Éñ¾­ÍËÐÐÐÔ¼²²¡£¨Neurodegenerative Disease, NDD£©ÊÇÒ»Àà·¢ÉúÔÚÉñ¾­ÏµÍ³ÖУ¬Ôì³ÉÉñ¾­Ôª¼°Æä¸½ÊôÊ÷Í»¡¢ÖáÍ»ºÍÍ»´¥£¬ÒÔ¼°±é²¼Éñ¾­ÏµÍ³µÄ½ºÖÊϸ°û·¢ÉúËðÉË»òÕß¹¦ÄÜʧ³£µÄ¼²²¡¡£Æä¿É·ÖΪ¼±ÐÔÉñ¾­ÍËÐÐÐÔ¼²²¡ºÍÂýÐÔÉñ¾­ÍËÐÐÐÔ¼²²¡£¬Ç°ÕßÖ÷Òª°üÀ¨ÄÔȱѪ£¨Cerebral Ischemia, CI£©¡¢ÄÔËðÉË£¨Brain Injury, BI£©¡¢ñ²ðEpilepsy£©µÈ£»ºóÕß°üÀ¨°¢¶û´Äº£Ä¬Ö¢£¨Alzheimer's Disease£©¡¢ÅÁ½ðÉ­²¡£¨Parkinson's Disease£©¡¢ºàÍ¢¶ÙÎ赸֢£¨Huntington's Disease£©¡¢¼¡Î®ËõÐÔ²àË÷Ó²»¯Ö¢£¨Amyotrophic Lateral Sclerosis, ALS£©µÈ¡£

    Ê×Ò³ > һվʽ·þÎñ > ²úÆ·ÖÐÐÄ > ¼²²¡Ä£ÐÍ > Éñ¾­ÍËÐÐÐÔ¼²²¡Ä£ÐÍ

            ¼¡Î®Ëõ²àË÷Ó²»¯Ö¢£¨Amyotrophic Lateral Sclerosis, ALS£©£¬ÓÖÃû¡°½¥¶³Ö¢¡±£¬ÊÇÒ»ÀàÓÉ´óÄԺͼ¹ËèÖÐÔ˶¯Éñ¾­ÔªËÀÍöÒýÆðµÄÈ«ÇòµÚÈý´óÉñ¾­ÍËÐÐÐÔ¼²²¡£¬±»ÊÀ½çÎÀÉú×éÖ¯ÁÐΪÎå´ó¾øÖ¢Ö®Ò»¡£Ä¿Ç°ALSµÄ·¢²¡»úÖÆÈÔ²»Ã÷È·£¬´æÔÚ²»Í¬¼Ù˵£¬·¢²¡»úÀíµÄÍÆ²âÖ÷ÒªÎ§ÈÆ»ùÒòÍ»±ä¡¢»·¾³ÎÛȾ¡¢ÖؽðÊôÖж¾¡¢²¡¶¾ÇÖȾµÈ¡£ÆäÖмÒ×åÐÔ»¼ÕßÔ¼Õ¼5%~10%£¬Ö÷ÒªÓÉ»ùÒòÍ»±äÔì³É¡£

            ½üÄêÀ´²»¶ÏÓÐALS·¢²¡Ïà¹Ø»ùÒò±»·¢ÏÖ£¬Æù½ñ±¨µÀµÄÔ¼Óм¸Ê®ÖÖ£¬ÒÑ·¢ÏÖµ¼Ö¼Ò×åÐÔALSµÄÍ»±ä»ùÒò°üÀ¨SOD1¡¢RNFºÍTARDBPµÈ¡£Õë¶ÔÕâЩALSµÄÈÈÃÅ»ùÒòÍ»±äλµã¼°Ò©ÎïÑо¿Í´µã£¬OGÊÓѶ¹ÙÍø·Ö±ð¹¹½¨ÁËÒÔÏÂÄ£ÐÍÒÔÂú×ãALSÒ©ÎïÑз¢ÐèÇó¡£